Wnt/β-catenin signaling pathway and its role in hepatocellular carcinoma

Wnt/β-catenin signaling pathway and its role in hepatocellular carcinoma

Abstract

Wnt/?-catenin signaling pathway has been identified as a key cellular pathway in embryogenesis and disease, including cancers. In recent years, more and more interacting components have been observed and their exact functions approached, thus ensuring the most complicated understanding of this pathway in normal organism development and disorders. In hepatocellular carcinoma (HCC), with a deeply understanding of this pathway, more and more genes which contribute to aberrant activation of Wnt/?-catenin signaling pathway has recently been identified and their exact roles in HCC pursued. In this review, we will focus on a mostly updated understanding of this pathway and its observed role in HCC by emphasizing the gene defects identified to promote tumorigenesis and development.

参考文献

1. de La Coste A, Romagnolo B, Billuart P, Renard C A, Buendia M A, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C . Somatic mutations of the b-catenin gene are frequentin mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA, 1998, 95(15): 8847–8851. doi:10.1073/pnas.95.15.8847
2. Cui J, Zhou X D, Liu Y K, Tang Z Y, Zile M H . Abnormal β-catenin gene expressionwith invasiveness of primary hepatocellular carcinoma in China. World J Gastroenterol, 2001, 7(4): 542–546
3. Arias A M . Epithelial mesenchymal interactions in cancer and development. Cell, 2001,105(4): 425–431. doi:10.1016/S0092‐8674(01)00365‐8
4. Moon R T, Bowerman B, Boutros M, Perrimon N . Thepromise and perils of Wnt signaling through beta-catenin. Science, 2002, 296(5573): 1644–1646. doi:10.1126/science.1071549
5. Peifer M, Polakis P . Wnt signaling in oncogenesisand embryogenesis-a look outside the nucleus. Science, 2000, 287(5458): 1606–1609. doi:10.1126/science.287.5458.1606
6. Weeraratna A T, Jiang Y, Hostetter G . Wnt5a signaling directly affects cell motility and invasionof metastatic melanoma. Cancer Cell, 2002, 1(3): 279–288. doi:10.1016/S1535‐6108(02)00045‐4
7. Rhee C S, Sen M, Lu D, Wu C, Leoni L, Rubin J, Corr M, Carson D A . Wnt and frizzled receptors as potential targets for immunotherapyin head and neck squamous cell carcinomas. Oncogene, 2002, 21(43): 6598–6605. doi:10.1038/sj.onc.1205920
8. Barker N, Morin P J, Clevers H . The Yin-Yang of TCF/beta-catenin signaling. Adv Cancer Res, 2000, 77: 1–24. doi:10.1016/S0065‐230X(08)60783‐6
9. Cong F, Schweizer L, Varmus H . Wnt signals across the plasma membrane to activate thebeta-catenin pathway by forming oligomers containing its receptors,Frizzled and LRP. Development, 2004, 131(20): 5103–5115. doi:10.1242/dev.01318
10. Logan C Y, Nusse R . The Wnt signaling pathwayin development and disease. Annu Rev CellDev Biol, 2004, 20: 781–810. doi:10.1146/annurev.cellbio.20.010403.113126
11. Wong H C, Bourdelas A, Krauss A, Lee H J, Shao Y, Wu D, Mlodzik M, Shi D L, Zheng J . Direct bindingof the PDZ domain of Dishevelled to a conserved internal sequencein the C-terminal region of Frizzled. MolCell, 2003, 12(5): 1251–1260. doi:10.1016/S1097‐2765(03)00427‐1
12. Wu C H, Nusse R . Ligand receptor interactionsin the Wnt signaling pathway in Drosophila. J Biol Chem, 2002, 277(44): 41762–41769. doi:10.1074/jbc.M207850200
13. Chen C M, Strapps W, Tomlinson A, Struhl G . Evidence thatthe cysteine-rich domain of Drosophila Frizzled family receptors isdispensable for transducing Wingless. ProcNatl Acad Sci USA, 2004, 101(45): 15961–15966. doi:10.1073/pnas.0407103101
14. Povelones M, Nusse R . The role of the cysteine-richdomain of Frizzled in Wingless-Armadillo signaling. EMBO J, 2005, 24(19): 3493–3503. doi:10.1038/sj.emboj.7600817
15. Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y, Hess F, Saint-Jeannet J P, He X . LDL-receptor-related proteins in Wnt signal transduction. Nature, 2000, 407(6803): 530–535. doi:10.1038/35035117
16. Wehrli M, Dougan S T, Caldwell K, O'Keefe L, Schwartz S, Vaizel-Ohayon D, Schejter E, Tomlinson A, DiNardo S . Arrow encodes an LDL-receptor-related protein essentialfor Wingless signaling. Nature, 2000, 407(6803): 527–530. doi:10.1038/35035110
17. Liu G, Bafico A, Harris V K, Aaronson S A . A novel mechanism for Wnt activation of canonical signaling throughthe LRP6 receptor. Mol Cell Biol, 2003, 23(16): 5825–5835. doi:10.1128/MCB.23.16.5825‐5835.2003
18. Holmen S L, Robertson S A, Zylstra C R, Williams B O . Wnt-independent activation of beta-catenin mediated by a Dkk1-Fz5fusion protein. Biochem Biophys Res Commun, 2005, 328(2): 533–539. doi:10.1016/j.bbrc.2005.01.009
19. Baig-Lewis S, Peterson-Nedry W, Wehrli M . Wingless/Wnt signal transduction requires distinct initiationand amplification steps that both depend on Arrow/LRP. Dev Biol, 2007, 306(1): 94–111. doi:10.1016/j.ydbio.2007.03.005
20. Xu Q, Wang Y, Dabdoub A, Smallwood P M, Williams J, Woods C, Kelley M W, Jiang L, Tasman W, Zhang K, Nathans J . Vascular development in the retina and inner ear: controlby Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell, 2004, 116(6): 883–895. doi:10.1016/S0092‐8674(04)00216‐8
21. Kim K A, Kakitani M, Zhao J, Oshima T, Tang T, Binnerts M, Liu Y, Boyle B, Park E, Emtage P, Funk W D, Tomizuka K . Mitogenic influence of humanR-spondin1 on the intestinal epithelium. Science, 2005, 309(5738): 1256–1259. doi:10.1126/science.1112521
22. Nam J S, Turcotte T J, Smith P F, Choi S, Yoon J K . Mouse cristin/R-spondin family proteinsare novel ligands for the Frizzled 8 and LRP6 receptors and activatebeta-catenin-dependent gene expression. J Biol Chem, 2006, 281(19): 13247–13257. doi:10.1074/jbc.M508324200
23. Kawano Y, Kypta R . Secreted antagonists of theWnt signaling pathway. J Cell Sci, 2003, 116(13): 2627–2634. doi:10.1242/jcs.00623
24. Semënov M V, Tamai K, Brott B K, Kühl M, Sokol S, He X . Head inducer Dickkopf-1 is a ligand for Wnt coreceptorLRP6. Curr Biol, 2001, 11(12): 951–961. doi:10.1016/S0960‐9822(01)00290‐1
25. Mao B, Wu W, Davidson G . Kremen proteins are Dickkopf receptors that regulateWnt/beta-catenin signaling. Nature, 2002, 417(6889): 664–667. doi:10.1038/nature756
26. Semënov M, Tamai K, He X . SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem, 2005, 280(29): 26770–26775. doi:10.1074/jbc.M504308200
27. Li X, Zhang Y, Kang H . Sclerostin binds to LRP5/6 and antagonizes canonicalWnt signaling. J Biol Chem, 2005, 280(20): 19883–19887. doi:10.1074/jbc.M413274200
28. Oishi I, Suzuki H, Onishi N, Takada R, Kani S, Ohkawara B, Koshida I, Suzuki K, Yamada G, Schwabe G C, Mundlos S, Shibuya H, Takada S, Minami Y . The receptortyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signallingpathway. Genes Cells, 2003, 8(7): 645–654. doi:10.1046/j.1365‐2443.2003.00662.x
29. Nishita M, Yoo S K, Nomachi A, Kani S, Sougawa N, Ohta Y, Takada S, Kikuchi A, Minami Y . Filopodia formationmediated by receptor tyrosine kinase Ror2 is required for Wnt5a-inducedcell migration. J Cell Biol, 2006, 175(4): 555–562. doi:10.1083/jcb.200607127
30. Lu W, Yamamoto V, Ortega B, Baltimore D . MammalianRyk is a Wnt coreceptor required for stimulation of neurite outgrowth. Cell, 2004, 119(1): 97–108. doi:10.1016/j.cell.2004.09.019
31. Kikuchi A, Yamamoto H, Kishida S . Multiplicity of the interactions of Wnt proteins andtheir receptors. Cell Signal, 2007, 19(4): 659–671. doi:10.1016/j.cellsig.2006.11.001
32. Hsieh J C, Kodjabachian L, Rebbert M L, Rattner A, Smallwood P M, Samos C H, Nusse R, Dawid I B, Nathans J . Anew secreted protein that binds to Wnt proteins and inhibits theiractivities. Nature, 1999, 398(6726): 431–436. doi:10.1038/18899
33. Amit S, Hatzubai A, Birman Y . Axin-mediated CKI phosphorylation of beta-catenin atSer 45: a molecular switch for the Wnt pathway. Genes Dev, 2002, 16(9): 1066–1076. doi:10.1101/gad.230302
34. Behrens J, Jerchow B A, Wurtele M, Grimm J, Asbrand C, Wirtz R, Kühl M, Wedlich D, Birchmeier W . Functionalinteraction of an axin homolog, conductin, with beta-catenin, APC,and GSK3beta. Science, 1998, 280(5363): 596–599. doi:10.1126/science.280.5363.596
35. Liu C, Li Y, Semenov M . Control of beta-catenin phosphorylation/degradation bya dual-kinase mechanism. Cell, 2002, 108(6): 837–847. doi:10.1016/S0092‐8674(02)00685‐2
36. Yanagawa S, Matsuda Y, Lee J S, Matsubayashi H, Sese S, Kadowaki T, Ishimoto A . Caseinkinase I phosphorylates the Armadillo protein and induces its degradationin Drosophila. EMBO J, 2002, 21(7): 1733–1742. doi:10.1093/emboj/21.7.1733
37. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R . Beta-catenin is a targetfor the ubiquitin-proteasome pathway. EMBOJ, 1997, 16(13): 3797–3804. doi:10.1093/emboj/16.13.3797
38. Zeng X, Tamai K, Doble B, Doble B, Li S, Huang H, Habas R, Okamura H, Woodgett J, He X . A dual-kinase mechanism for Wnt co-receptor phosphorylationand activation. Nature, 2005, 438(7069): 873–877. doi:10.1038/nature04185
39. Davidson G, Wu W, Shen J, Bilic J, Fenger U, Stannek P, Glinka A, Niehrs C . Casein kinase 1γ couples Wnt receptor activationto cytoplasmic signal transduction. Nature, 2005, 438(7069): 867–872. doi:10.1038/nature04170
40. Brennan K, Gonzalez-Sancho JM, Castelo-Soccio L A, Howe L R, Brown A M . Truncatedmutants of the putative Wnt receptor LRP6/Arrow can stabilize beta-cateninindependently of Frizzled proteins. Oncogene, 2004, 23(28): 4873–4884. doi:10.1038/sj.onc.1207642
41. Chen W, ten Berge D, Brown J, Ahn S, Hu L A, Miller W E, Caron M G, Barak L S, Nusse R, Lefkowitz R J . Dishevelled 2 recruits beta-arrestin2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4. Science, 2003, 301(5638): 1391–1394. doi:10.1126/science.1082808
42. Klein T J, Jenny A, Djiane A, Mlodzik M . CKIϵ/discsovergrown Promotes Both Wnt-Fz/β-Catenin and Fz/PCP Signalingin Drosophila. Current Biology, 2006, 16(13): 1337–1343. doi:10.1016/j.cub.2006.06.030
43. Ding Y, Dale T . Wnt signal transduction:kinase cogs in a nano-machine?Trends Biochem Sci, 2002, 27(7): 327–329. doi:10.1016/S0968‐0004(02)02137‐0
44. Sun T Q, Lu B, Feng J J, Reinhard C, Jan Y N, Fantl W J, Williams L T . PAR-1 is a Dishevelled-associated kinase and a positive regulatorof Wnt signaling. Nat Cell Biol, 2001, 3(7): 628–636. doi:10.1038/35083016
45. Seldin D C, Landesman-Bollag E, Farago M, Currier N, Lou D, Dominguez I . CK2 as a positive regulator of Wnt signaling and tumourigenesis. Mol Cell Biochem, 2005, 274(1–2): 63–67. doi:10.1007/s11010‐005‐3078‐0
46. Li L, Yuan H, Weaver C D, Mao J, Farr G H 3rd, Sussman D J, Jonkers J, Kimelman D, Wu D . Axin and Frat1interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulationof LEF-1. EMBO J, 1999, 18(15): 4233–4240. doi:10.1093/emboj/18.15.4233
47. Salic A, Lee E, Mayer L, Kirschner M W . Control of beta-catenin stability: reconstitution of the cytoplasmicsteps of the wnt pathway in Xenopus egg extracts. Mol Cell, 2000, 5(3): 523–532. doi:10.1016/S1097‐2765(00)80446‐3
48. Ossipova O, Bardeesy N, DePinho R A, Green J B . B1 (XEEK1)regulates Wnt signalling in vertebrate Development. Nat Cell Biol, 2003, 5(10): 889–894. doi:10.1038/ncb1048
49. Spicer J, Rayter S, Young N, Elliott R, Ashworth A, Smith D . Regulation of the Wnt signalling component PAR1A by thePeutz-Jeghers syndrome kinase LKB1. Oncogene, 2003, 22(30): 4752–4756. doi:10.1038/sj.onc.1206669
50. Cliffe A, Hamada F, Bienz M . A role of Dishevelled in relocating Axin to the plasmamembrane during wingless signaling. CurrBiol, 2003, 13(11): 960–966. doi:10.1016/S0960‐9822(03)00370‐1
51. Mao J, Wang J, Liu B, Pan W, Farr G H 3rd, Flynn C, Yuan H, Takada S, Kimelman D, Li L, Wu D . Low-density lipoprotein receptor-related protein-5 bindsto Axin and regulates the canonical Wnt signaling pathway. Mol Cell, 2001, 7(4): 801–809. doi:10.1016/S1097‐2765(01)00224‐6
52. Brunner E, Peter O, Schweizer L, Basler K . Pangolin encodesa Lef-1 homologue that acts downstream of Armadillo to transduce theWingless signal in Drosophila. Nature, 1997, 385(6619): 829–833. doi:10.1038/385829a0
53. van de Wetering M, Cavallo R, Dooijes D, van Beest M, van Es J, Loureiro J, Ypma A, Hursh D, Jones T, Bejsovec A, Peifer M, Mortin M, Clevers H . Armadillo coactivates transcription drivenby the product of the Drosophila segment polarity gene dTCF. Cell, 1997, 88(6): 789–799. doi:10.1016/S0092‐8674(00)81925‐X
54. Bienz M . TCF:transcriptional activator or repressor?Curr Opin Cell Biol, 1998, 10(3): 366–372. doi:10.1016/S0955‐0674(98)80013‐6
55. Cavallo R A, Cox R T, Moline M M, Roose J, Polevoy G A, Clevers H, Peifer M, Bejsovec A . Drosophila Tcf and Groucho interact to repress Winglesssignalling activity. Nature, 1998, 395(6702): 604–608. doi:10.1038/26982
56. Chen G, Fernandez J, Mische S, Courey A J . A functionalinteraction between the histone deacetylase Rpd3 and the corepressorgroucho in Drosophila development. GenesDev, 1999, 13(17): 2218–2230. doi:10.1101/gad.13.17.2218
57. Henderson B R, Fagotto F . The ins and outs of APC andbeta-catenin nuclear transport. EMBO Rep, 2002, 3(9): 834–839. doi:10.1093/embo‐reports/kvf181
58. Rosin-Arbesfeld R, Townsley F, Bienz M . APC has a nuclear export function. Nature, 2000, 406(6799): 1009–1012. doi:10.1038/35023016
59. Rosin-Arbesfeld R, Cliffe A, Brabletz T, Bienz M . Nuclear exportof the APC tumour suppressor controls beta-catenin function in transcription. EMBO J, 2003, 22(5): 1101–1113. doi:10.1093/emboj/cdg105
60. Townsley F M, Cliffe A, Bienz M . Pygopus and Legless target Armadillo/β-catenin tothe nucleus to enable its transcriptional co-activator function. Nat Cell Biol, 2004, 6(7): 626-633. doi:10.1038/ncb1141
61. Hoffmans R, Städeli R, Basler K . Pygopus and legless provide essential transcriptionalcoactivator functions to armadillo/beta-catenin. Curr Biol, 2005, 15(13): 1207–1211. doi:10.1016/j.cub.2005.05.054
62. Daniels D L, Weis W I . β-catenin directly displacesGroucho/TLE repressor from Tcf/Lef in Wnt-mediated transcription activation. Nat Struct Mol Biol, 2005, 12(4): 364–371. doi:10.1038/nsmb912
63. Hecht A, Vleminckx K, Stemmler M P, van Roy F, Kemler R . The p300/CBP acetyltransferasesfunction as transcriptional coactivators of beta-catenin in vertebrates. EMBO J, 2000, 19(8): 1839–1850. doi:10.1093/emboj/19.8.1839
64. Takemaru K I, Moon R T . The transcriptional coactivatorCBP interacts with beta-catenin to activate gene expression. J Cell Biol, 2000, 149(2): 249–254. doi:10.1083/jcb.149.2.249
65. Li J, Sutter C, Parker D S, Blauwkamp T, Fang M, Cadigan K M . CBP/p300 are bimodal regulators of Wnt signaling. EMBO J, 2007, 26(9): 2284–2294. doi:10.1038/sj.emboj.7601667
66. Barker N, Hurlstone A, Musisi H, Miles A, Bienz M, Clevers H . Thechromatin remodeling factor Brg-1 interacts with beta-catenin to promotetarget gene activation. EMBO J, 2001, 20(17): 4935–4943. doi:10.1093/emboj/20.17.4935
67. Thompson B, Townsley F, Rosin-Arbesfeld R, Musisi H, Bienz M . A new nuclear component ofthe Wnt signalling pathway. Nat Cell Biol, 2002, 4(5): 367–373. doi:10.1038/ncb786
68. Kramps T, Peter O, Brunner E, Nellen D, Froesch B, Chatterjee S, Murone M, Züllig S, Basler K . Wnt/winglesssignaling requires BCL9/legless-mediated recruitment of pygopus tothe nuclear beta-catenin-TCF complex. Cell, 2002, 109(1): 47–60. doi:10.1016/S0092‐8674(02)00679‐7
69. Parker D S, Jemison J, Cadigan K M . Pygopus, a nuclear PHD-fingerprotein required for Winglesssignaling in Drosophila. Development, 2002, 129(11): 2565–2576
70. Mosimann C, Hausmann G, Basler K . Parafibromin/Hyrax activates Wnt/Wg target gene transcriptionby direct association with beta-catenin/Armadillo. Cell, 2006, 125(2): 327–341. doi:10.1016/j.cell.2006.01.053
71. Hoffmans R, Basler K . BCL9-2 binds Arm/beta-cateninin a Tyr142-independent manner and requires Pygopus for its functionin Wg/Wnt signaling. Mech Dev, 2007, 124(1): 59-67. doi:10.1016/j.mod.2006.09.006
72. de la Roche M, Bienz M . Wingless-independent associationof Pygopus with dTCF target genes. CurrBiol, 2007, 17(6): 556–561. doi:10.1016/j.cub.2007.01.063
73. Olson L E, Tollkuhn J, Scafoglio C, Krones A, Zhang J, Ohgi K A, Wu W, Taketo M M, Kemler R, Grosschedl R, Rose D, Li X, Rosenfeld M G . Homeodomain-mediated beta-catenin-dependent switchingevents dictate cell-lineage determination. Cell, 2006, 125(3): 593–605. doi:10.1016/j.cell.2006.02.046
74. Kioussi C, Briata P, Baek S H, Rose D W, Hamblet N S, Herman T, Ohgi K A, Lin C, Gleiberman A, Wang J, Brault V, Ruiz-Lozano P, Nguyen H D, Kemler R, Glass C K, Wynshaw-Boris A, Rosenfeld M G . Identification of a Wnt/Dvl/beta-Catenin → Pitx2pathway mediating cell-type-specific proliferation during development. Cell, 2002, 111(5): 673–685. doi:10.1016/S0092‐8674(02)01084‐X
75. Sinner D, Rankin S, Lee M, Zorn A M . Sox17 andbeta-catenin cooperate to regulate the transcription of endodermalgenes. Development, 2004, 131(13): 3069–3080. doi:10.1242/dev.01176
76. Ishitani T, Ninomiya-Tsuji J, Matsumoto K . Regulation of lymphoid enhancer factor 1/T-cell factorby mitogen-activated protein kinase-related Nemo-like kinase-dependentphosphorylation in Wnt/beta-catenin signaling. Mol Cell Biol, 2003, 23(4): 1379–1389. doi:10.1128/MCB.23.4.1379‐1389.2003
77. Ishitani T, Kishida S, Hyodo-Miura J, Ueno N, Yasuda J, Waterman M, Shibuya H, Moon R T, Ninomiya-Tsuji J . TheTAK1-NLK mitogen-activated protein kinase cascade functions in theWnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Mol Cell Biol, 2003, 23(1): 131–139. doi:10.1128/MCB.23.1.131‐139.2003
78. Gottardi C J, Gumbiner B M . Role for ICAT in beta-catenin-dependentnuclear signaling and cadherin functions. Am J Physiol Cell Physiol, 2004, 286(4): C747–756. doi:10.1152/ajpcell.00433.2003
79. Takemaru K, Yamaguchi S, Lee Y S, Zhang Y, Carthew R W, Moon R T . Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Winglesspathway. Nature, 2003, 422(6934): 905–909. doi:10.1038/nature01570
80. Bauer A, Chauvet S, Huber O, Usseglio F, Rothbächer U, Aragnol D, Kemler R, Pradel J . Pontin52 and reptin52 function as antagonisticregulators of beta-catenin signaling activity. EMBO J, 2000,19(22): 6121–6130. doi:10.1093/emboj/19.22.6121
81. Bauer A, Huber O, Kemler R . Pontin52, an interaction partner of beta-catenin, bindsto the TATA box binding protein. Proc NatlAcad Sci USA, 1998, 95(25): 14787–14792. doi:10.1073/pnas.95.25.14787
82. Waltzer L, Bienz M . Drosophila CBP repressesthe transcription factor TCF to antagonize Wingless signaling. Nature, 1998, 395(6701): 521–525. doi:10.1038/26785
83. Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, Monges G, Thomas G, Bioulac-Sage P, Zucman-Rossi J . Genetic alterations associatedwith hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology, 2001, 120(7): 1763–1773. doi:10.1053/gast.2001.24798
84. Peifer M, Polakis P . Wnt signaling in oncogenesisand embryogenesis–a look outside the nucleus. Science, 2000, 287(5458): 1606–1609. doi:10.1126/science.287.5458.1606
85. Polakis P . Wntsignaling and cancer. Genes Dev, 2000, 14(15): 1837–1851
86. Kondo Y, Kanai Y, Sakamoto M, Genda T, Mizokami M, Ueda R, Hirohashi S . Beta-catenin accumulationand mutation of exon 3 of the beta-catenin gene in hepatocellularcarcinoma. Jpn J Cancer Res, 1999, 90(12): 1301–1309
87. Legoix P, Bluteau O, Bayer J, Perret C, Balabaud C, Belghiti J, Franco D, Thomas G, Laurent-Puig P, Zucman-Rossi J . Beta-catenin mutations inhepatocellular carcinoma correlate with a low rate of loss of heterozygosity. Oncogene, 1999, 18(27): 4044–4046. doi:10.1038/sj.onc.1202800
88. Nhieu J T, Renard C A, Wei Y, Cherqui D, Zafrani E S, Buendia M A . Nuclear accumulation of mutated beta-catenin in hepatocellularcarcinoma is associated with increased cell proliferation. Am J Pathol, 1999, 155(3): 703–710
89. Wong C M, Fan S T, Ng I O . beta-Catenin mutation and overexpression in hepatocellularcarcinoma: clinicopathologic and prognostic significance. Cancer, 2001, 92(1): 136–145. doi:10.1002/1097‐0142(20010701)92:1<136::AID‐CNCR1301>3.0.CO;2‐R
90. Cui J, Zhou X D, Liu Y K, Tang Z Y . Mutationand overexpression of β-catenin gene may play an important rolein primary hepatocellular carcinoma among Chinese people. J Cancer Res Clin Oncol, 2001, 127(8): 577–581. doi:10.1007/s004320100259
91. Cui J, Zhou X D, Liu Y K, Tang Z, Romeih M . Wnt signaling in hepatocellular carcinoma:Analysis of mutation and expression of beta-catenin, T-cell factor-4and glycogen synthase kinase 3-beta genes. J Gastroenterol Hepatol, 2003, 18(3): 280–287. doi:10.1046/j.1440‐1746.2003.02973.x
92. Huang H, Fujii H, Sankila A, Mahler-Araujo B M, Matsuda M, Cathomas G, Ohgaki H . Beta-cateninmutations are frequent in human hepatocellular carcinomas associatedwith hepatitis C virus infection. Am JPathol, 1999, 155(6): 1795–1801
93. Cui J, Zhou X, Liu Y, Tang Z, Romeih M . Alterations of beta-catenin and Tcf-4instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellularcarcinoma. Chin Med J (Engl), 2003, 116(12): 1885–1892
94. Hsu H C, Jeng Y M, Mao T L, Chu J S, Lai P L, Peng S Y . Beta-Catenin Mutations Are Associated with a Subset of Low-StageHepatocellular Carcinoma Negative for Hepatitis B Virus and with FavorablePrognosis. Am J Pathol, 2000, 157(3): 763–770
95. Tien L T, Ito M, Nakao M, Niino D, Serik M, Nakashima M, Wen C Y, Yatsuhashi H, Ishibashi H . Expressionof β-catenin in hepatocellular carcinoma. World J Gastroenterol, 2005, 11(16): 2398–2401
96. Devereux T R, Stern M C, Flake G P, Yu M C, Zhang Z Q, London S J, Taylor J A . CTNNB1 mutations and beta-cateninprotein accumulation in human hepatocellular carcinomas associatedwith high exposure to aflatoxin B1. MolCarcinog, 2001, 31(2): 68–73. doi:10.1002/mc.1041
97. Edamoto Y, Hara A, Biernat W, Terracciano L, Cathomas G, Riehle H M, Matsuda M, Fujii H, Scoazec J Y, Ohgaki H . Alterationsof RB1, p53and Wnt pathways in hepatocellular carcinomas associatedwith hepatitis C, hepatitis B and alcoholic liver cirrhosis. Int J Cancer, 2003, 106(3): 334–341. doi:10.1002/ijc.11254
98. Laurent-Puig P, Zucman-Rossi J . Genetics of hepatocellulartumors. Oncogene, 2006, 25(27): 3778–3786. doi:10.1038/sj.onc.1209547
99. Cha M Y, Kim C M, Park Y M, Ryu W S . HepatitisB virus X protein is essential for the activation of Wnt/bcateninsignaling in hepatoma cells. Hepatology, 2004, 39(6): 1683–1693. doi:10.1002/hep.20245
100. Mao T L, Chu J S, Jeng Y M, Lai P L, Hsu H C . Expression of mutant nuclear beta-catenincorrelates with noninvasive hepatocellular carcinoma, absence of portalvein spread, and good prognosis. J Pathol, 2001, 193(1): 95–101. doi:10.1002/1096‐9896(2000)9999:9999<::AID‐PATH720>3.0.CO;2‐3
101. Schmitt-Graff A, Ertelt V, Allgaier H P, Koelble K, Olschewski M, Nitschke R, Bochaton-Piallat M L, Gabbiani G, Blum H E . Cellular retino-l-binding protein-1 in hepatocellularcarcinoma correlates with beta-catenin, Ki-67 index, and patient survival. Hepatology, 2003, 38(2): 470–480. doi:10.1053/jhep.2003.50321
102. Kielhorn E, Provost E, Olsen D, D'Aquila T G, Smith B L, Camp R L, Rimm D L . Tissue microarray-basedanalysis shows phospho-beta-catenin expression in malignant melanomais associated with poor outcome. Int JCancer, 2003, 103(5): 652–656. doi:10.1002/ijc.10893
103. Zeng G, Awan F, Otruba W, Muller P, Apte U, Tan X, Gandhi C, Demetris A J, Monga S P . Wnt'er inliver: expression of Wnt and Frizzled genes in mouse. Hepatology, 2007, 45(1): 195–2041. doi:10.1002/hep.21473
104. Calvisi D F, Conner E A, Ladu S, Lemmer E R, Factor V M, Thorgeirsson S S . Activation of the canonical Wnt/β-catenin pathway confers growthadvantages in c-Myc/E2F1 transgenic mouse model of liver cancer. J Hepatol, 2005, 42(6): 842–849. doi:10.1016/j.jhep.2005.01.029
105. Merle P, de la Monte S, Kim M, Herrmann M, Tanaka S, Von Dem Bussche A . Functional consequences of frizzled-7receptor overexpression in human hepatocellular carcinoma. Gastroenterology, 2004, 127(4): 1110–1122. doi:10.1053/j.gastro.2004.07.009
106. Merle P, Kim M, Herrmann M, Gupte A, Lefranc¸ois L, Califano S, Trépo C, Tanaka S, Vitvitski L, de la Monte S, Wands J R . Oncogenic role of the frizzled-7/b-cateninpathway in hepatocellular carcinoma. JHepatol, 2005, 43(5): 854–862. doi:10.1016/j.jhep.2005.05.018
107. Shih Y L, Shyu R Y, Hsieh B C, Lai H C, Liu K Y, Chu T Y, Lin Y W . Promoter methylation of thesecreted Frizzled-related protein 1 gene SFRP1 is frequent in hepatocellularcarcinoma. Cancer, 2006, 107(3): 579–590. doi:10.1002/cncr.22023
108. Shih Y L, Hsieh B C, Lai H C, Yan M D, Hsieh T Y, Chao Y C, Lin Y W . SFRP1 suppressed hepatomacells growth through Wnt canonical signaling pathway. Int J Cancer, 2007, 121(5): 1028–1035. doi:10.1002/ijc.22750
109. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y . AXIN1 mutations in hepatocellular carcinomas, and growthsuppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet, 2000, 24(3): 245–250. doi:10.1038/73448
110. Taniguchi K, Roberts L R, Aderca I N, Dong X, Qian C, Murphy L M, Nagorney D M, Burgart L J, Roche P C, Smith D I, Ross J A, Liu W . Mutational spectrum of beta-catenin,AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene, 2002, 21(31): 4863–4871. doi:10.1038/sj.onc.1205591
111. Zucman-Rossi J, Benhamouche S, Godard C, Boyault S, Grimber G, Balabaud C, Cunha A S, Bioulac-Sage P, Perret C . Differential effects of inactivated Axin1 and activated β-cateninmutations in human hepatocellular carcinomas. Oncogene, 2007, 26(5): 774–780. doi:10.1038/sj.onc.1209824
112. Ishizaki Y, Ikeda S, Fujimori M, Shimizu Y, Kurihara T, Itamoto T, Kikuchi A, Okajima M, Asahara T . Immunohistochemical analysis and mutational analysesof beta-catenin, Axin family and APC genes in hepatocellular carcinomas. Int J Oncol, 2004, 24(5): 1077–1083
113. Sparks A B, Morin P J, Vogelstein B, Kinzler K W . Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectalcancer. Cancer Res, 1998, 58(6): 1130–1134
114. Utherland C, Leighton I A, Cohen P . Inactivation of glycogen synthase kinase-3 beta by phosphorylation:New kinase connections in insulin and growth-factor signaling. Biochem J, 1993, 296(Pt 1): 15–19
115. Ban K C, Singh H, Krishnan R, Seow H F . GSK-3betaphosphorylation and alteration of beta-catenin in hepatocellular carcinoma. Cancer Lett, 2003, 199(2): 201–208. doi:10.1016/S0304‐3835(03)00421‐X
116. Chen T C, Hsieh L L, Ng K F, Jeng L B, Chen M F . Absence of APC gene mutation in the mutationcluster region in hepatocellular carcinoma. Cancer Lett, 1998, 134(1): 23–28. doi:10.1016/S0304‐3835(98)00238‐9
117. Katoh H, Shibata T, Kokubu A, Ojima H, Kosuge T, Kanai Y, Hirohashi S . Genetic inactivation of theAPC gene contributes to the malignant progression of sporadic hepatocellularcarcinoma: a case report. Genes ChromosomesCancer, 2006, 45(11): 1050–1057. doi:10.1002/gcc.20362
118. Colnot S, Decaens T, Niwa-Kawakita M, Godard C, Hamard G, Kahn A, Giovannini M, Perret C . Liver-targeted disruption of Apc in mice activates beta-cateninsignaling and leads to hepatocellular carcinomas. Proc Natl Acad Sci U S A, 2004, 101(49): 17216–17221. doi:10.1073/pnas.0404761101
119. Jiang Y, Zhou X D, Liu Y K, Wu X, Huang X W . Association of hTcf-4 gene expressionand mutation with clinicopathological characteristics of hepatocellularcarcinoma. World J Gastroenterol, 2002, 8(5): 804–807
120. Cadoret A, Ovejero C, Saadi-Kheddouci S, Souil E, Fabre M, Romagnolo B, Kahn A, Perret C . Hepatomegaly in transgenic mice expressingan oncogenic form of beta-catenin. CancerRes, 2001, 61(8): 3245–3249
121. Prange W, Breuhahn K, Fischer F, Zilkens C, Pietsch T, Petmecky K, Eilers R, Dienes H P, Schirmacher P . Beta-cateninaccumulation in the progression of human hepatocarcinogenesis correlateswith loss of E-cadherin and accumulation of p53, but not with expressionof conventional WNT-1 target genes. J Pathol, 2003, 201(2): 250–259. doi:10.1002/path.1448
122. Schmitt-Graeff A, Ertelt-Heitzmann V, Allgaier H P, Olschewski M, Nitschke R, Haxelmans S, Koelble K, Behrens J, Blum H E . Coordinated expression of cyclin D1 and LEF-1/TCF transcriptionfactor is restricted to a subset of hepatocellular carcinoma. Liver Int, 2005, 25(4): 839–847. doi:10.1111/j.1478‐3231.2005.01069.x
123. Du Q, Park K S, Guo Z, He P, Nagashima M, Shao L, Sahai R, Geller D A, Hussain S P . Regulation of human nitric oxide synthase 2 expression by Wnt beta-cateninsignaling. Cancer Res, 2006, 66(14): 7024–7031. doi:10.1158/0008‐5472.CAN‐05‐4110
124. Yamamoto Y, Sakamoto M, Fujii G, Tsuiji H, Kenetaka K, Asaka M, Hirohashi S . Overexpression of orphanG-protein-coupled receptor, Gpr49, in human hepatocellular carcinomaswith beta-catenin mutations. Hepatology, 2003, 37(3): 528–533. doi:10.1053/jhep.2003.50029
125. Tan X P, Apte U, Micsenyi A, Kotsagrelos E, Luo J H, Ranganathan S, Monga D K, Bell A . Epidermal growth factor receptor: A noveltarget of the Wnt/β-catenin pathway in liver. Gastroenterology, 2005, 129(1): 285–302. doi:10.1053/j.gastro.2005.04.013
126. Cavard C, Terris B, Grimber G, Christa L, Audard V, Radenen-Bussiere B, Simon M T, Renard C A, Buendia M A, Perret C . Overexpressionof regenerating islet-derived 1 alpha and 3 alpha genes in human primaryliver tumors with β-catenin mutations. Oncogene, 2006, 25(4): 599–608. doi:10.1038/sj.onc.1208860
127. Renard C A, Labalette C, Armengol C, Cougot D, Wei Y, Cairo S, Pineau P, Neuveut C, de Reyniàs A, Dejean A, Perret C, Buendia M A . Tbx3 is a downstream targetof the Wnt/beta-catenin pathway and a critical mediator of beta-cateninsurvival functions in liver cancer. CancerRes, 2007, 67(3): 901–910. doi:10.1158/0008‐5472.CAN‐06‐2344
128. Lee H S, Park M H, Yang S J, Park K C, Kim N S, Kim Y S, Kim D I, Yoo H S, Choi E J, Yeom Y I . Novel candidate target of Wnt/β-cateninsignaling in hepatoma cells. Life Sci, 2007, 80(7): 690–698. doi:10.1016/j.lfs.2006.10.024
129. Harada N, Miyoshi H, Murai N, Oshima H, Tamai Y, Oshima M, Taketo M M . Lack of tumorigenesis inthe mouse liver after adenovirus-mediated expression of a dominantstable mutant of beta-catenin. Cancer Res, 2002, 62(7): 1971–1977
130. Harada N, Oshima H, Katoh M, Tamai Y, Oshima M, Taketo M M . Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations. Cancer Res, 2004, 64(1): 48–54. doi:10.1158/0008‐5472.CAN‐03‐2123
131. James Nelson W, Nusse R . Convergence of Wnt, β-catenin,and cadherin pathways. Science, 2004, 303(5663): 1483–1487. doi:10.1126/science.1094291
132. Essers M A, de Vries-Smits L M, Barker N, Polderman P E, Burgering B M, Korswagen H C . Functional Interaction between β-catenin and FOXOin oxidative stress signaling. Science, 2005, 308(5725): 1081–1184. doi:10.1126/science.1109083